JAPAN DAYBOOK: Bank of Japan Policy, Yahoo Japan

The Bank of Japan ends a two-day policy meeting, the first since Prime Minister Naoto Kan named Kaoru Yosano economy minister in a cabinet reshuffle. Yosano has opposed pressuring the bank to for more easing.

WHAT TO WATCH *Bank of Japan policy announcement, including an outlook for growth and prices. Time not scheduled. *Bank of Japan Governor Shirakawa briefing at 3:30 p.m. *Cabinet meeting at 10 a.m., followed by minister briefings.

EARNINGS Yahoo Japan (4689 JT) 3:10 p.m. *Nidec (6594 JO) 3:30 p.m. *Shin-Etsu Chemical (4063 JT).

EQUITY PREVIEW *Dainippon Screen Manufacturing (7735 JT) probably received 45 billion yen worth of orders for semiconductor- manufacturing equipment during the October-December period, an increase of 32 percent, the Nikkei newspaper said. Don Quijote (7532 JT) will probably report a 22 percent gain in first-half operating profit, to 13.5 billion yen, the Nikkei newspaper reported. *Teijin (3401 JT) will probably report net income of more than 20 billion yen for the nine months that ended in December, the Nikkei newspaper reported. The company will probably raise its full-year forecast to 25 billion yen from 21 billion yen, according to the report. *Toray Industries (3402 JT) and Daimler AG agreed to form a venture in Germany to produce carbon-fiber auto parts. *Tsumura & Co. (4540 JT) may post a record operating profit for the April-December period because of increasing domestic sales of herbal medicines, the Nikkei newspaper said. Operating profit probably rose 3 percent to 16 billion yen and sales probably rose 1 percent to 71 billion yen, the report said. Yamaha Corp. (7951 JT) may say April-December operating profit rose 25 percent to 13 billion yen, the Nikkei newspaper reported.

ANALYST RATINGS FOR NIKKEI 225 COMPANIES *Asahi Breweries (2502 JT) initiated neutral at Mitsubishi UFJ Morgan. *Furukawa Electric (5801 JT) cut to neutral at Goldman. *Chugai Pharmaceutical (4519 JT) raised to overweight at Morgan.

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.